The digital biomarkers market is expected to grow rapidly over the forecast period, owing to rising digitalization, rising usage of digital biomarkers, elevating the global population coupled with the geriatric population, improving reimbursement policies, and public initiatives and funding to develop technologically advanced products. Due to the COVID-19 pandemic, the market's growth was propelled in 2020 and has been rising since then. The following figure represents the market size of the global digital biomarkers market in the period 2022-2028.
High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for digital biomarkers market growth. In an era of machine learning (ML) and artificial intelligence (AI), extracting quantitative digital biomarkers that help in illness detection, characterization, monitoring, and therapy response assessment is becoming increasingly desirable.